nab-Paclitaxel potentiates gemcitabine activity by reducing cytidine deaminase levels in a mouse model of pancreatic cancer.

K.K. Frese, A. Neesse, N. Cook, T.E. Bapiro, M.P.J.K. Lolkema, D.I. Jodrell, D.A. Tuveson

Research output: Contribution to journal › Article › Academic › peer-review

Access to Document

@article{f5d69d1e3aeb4c70bc6bba6e5245a64d,

title = "nab-Paclitaxel potentiates gemcitabine activity by reducing cytidine deaminase levels in a mouse model of pancreatic cancer.",

author = "K.K. Frese and A. Neesse and N. Cook and T.E. Bapiro and M.P.J.K. Lolkema and D.I. Jodrell and D.A. Tuveson",

year = "2012",

language = "English",

volume = "2",

pages = "260--269",

journal = "Cancer Discovery",

issn = "2159-8274",

publisher = "American Association for Cancer Research Inc.",

number = "3",

}

TY - JOUR

T1 - nab-Paclitaxel potentiates gemcitabine activity by reducing cytidine deaminase levels in a mouse model of pancreatic cancer.

AU - Frese, K.K.

AU - Neesse, A.

AU - Cook, N.

AU - Bapiro, T.E.

AU - Lolkema, M.P.J.K.

AU - Jodrell, D.I.

AU - Tuveson, D.A.

PY - 2012

Y1 - 2012

M3 - Article

SN - 2159-8274

VL - 2

SP - 260

EP - 269

JO - Cancer Discovery

JF - Cancer Discovery

IS - 3

ER -